Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank:DB05923_nanopub.RAV2nsi3Pt33rnEpfKxgQgZLtPgKRUBXXRLfn13SqwpEQ#assertion>. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05923 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05923 label "ECO-4601 [drugbank:DB05923]" assertion.
- drugbank:DB05923 seeAlso DB05923 assertion.
- drugbank:DB05923 description "ECO-4601 is a proprietary first-in-class small molecule with the potential to treat multiple solid tumours like the well known chemotherapeutics, doxorubicin and mitomycin C. ECO-4601 is a natural product derived from a non-pathogenic micro-organism. Discovered using Thallionâs DECIPHER technology, ECO-4601 has completed preclinical studies conducted by the National Cancer Institute and Thallion to establish safety and efficacy in animal and in vitro models." assertion.
- drugbank:DB05923 identifier "drugbank:DB05923" assertion.
- drugbank:DB05923 title "ECO-4601" assertion.
- drugbank:DB05923 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05923 drugbank_vocabulary:drugbank-id "DB05923" assertion.
- drugbank:DB05923 bio2rdf_vocabulary:x-identifiers.org DB05923 assertion.
- drugbank:DB05923 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05923" assertion.
- drugbank:DB05923 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05923 bio2rdf_vocabulary:identifier "DB05923" assertion.